

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.36040201 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.71420219 |
| 3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.49009112 |
| 4 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.44860919 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24098797 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.24098797 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24098797 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24098797 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24098797 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.24098797 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.09245061 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.04611267 |
| 13 | microglial cell activation (GO:0001774) | 4.01628661 |
| 14 | short-term memory (GO:0007614) | 3.90977211 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 3.87714109 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.83846188 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.77678278 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.75155130 |
| 19 | exploration behavior (GO:0035640) | 3.73505386 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.69900182 |
| 21 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.65087461 |
| 22 | neutrophil mediated immunity (GO:0002446) | 3.64865987 |
| 23 | dendritic spine morphogenesis (GO:0060997) | 3.60279583 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 3.48900397 |
| 25 | nucleobase catabolic process (GO:0046113) | 3.48812967 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.42776764 |
| 27 | postsynaptic membrane organization (GO:0001941) | 3.39832589 |
| 28 | protein localization to synapse (GO:0035418) | 3.30897957 |
| 29 | myeloid leukocyte mediated immunity (GO:0002444) | 3.27526849 |
| 30 | neuronal action potential propagation (GO:0019227) | 3.26128451 |
| 31 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.22497269 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.20123256 |
| 33 | response to peptidoglycan (GO:0032494) | 3.17625352 |
| 34 | establishment of mitochondrion localization (GO:0051654) | 3.16273134 |
| 35 | presynaptic membrane assembly (GO:0097105) | 3.15913988 |
| 36 | synaptic vesicle endocytosis (GO:0048488) | 3.14884555 |
| 37 | transmission of nerve impulse (GO:0019226) | 3.13088316 |
| 38 | vocalization behavior (GO:0071625) | 3.12276388 |
| 39 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.10609762 |
| 40 | axonal fasciculation (GO:0007413) | 3.09367160 |
| 41 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.07491699 |
| 42 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03908101 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03604264 |
| 44 | presynaptic membrane organization (GO:0097090) | 3.03067300 |
| 45 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.00729966 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 2.99183851 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.98546411 |
| 48 | neuron-neuron synaptic transmission (GO:0007270) | 2.98343797 |
| 49 | synaptic transmission, glutamatergic (GO:0035249) | 2.98315743 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 2.98110657 |
| 51 | behavioral response to cocaine (GO:0048148) | 2.97509619 |
| 52 | adult walking behavior (GO:0007628) | 2.97051846 |
| 53 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97008505 |
| 54 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.95127140 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94806596 |
| 56 | negative regulation of cell killing (GO:0031342) | 2.94806596 |
| 57 | neurofilament cytoskeleton organization (GO:0060052) | 2.94303944 |
| 58 | neuron fate determination (GO:0048664) | 2.94023219 |
| 59 | macrophage activation (GO:0042116) | 2.92695365 |
| 60 | glutamate secretion (GO:0014047) | 2.92006173 |
| 61 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.89620959 |
| 62 | neuron recognition (GO:0008038) | 2.88214912 |
| 63 | respiratory burst (GO:0045730) | 2.87040134 |
| 64 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.83515997 |
| 65 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.79869874 |
| 66 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.78079142 |
| 67 | regulation of neurotransmitter secretion (GO:0046928) | 2.77978286 |
| 68 | neuronal ion channel clustering (GO:0045161) | 2.76728467 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 2.75447706 |
| 70 | layer formation in cerebral cortex (GO:0021819) | 2.74250999 |
| 71 | L-amino acid import (GO:0043092) | 2.74227685 |
| 72 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.73235822 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72355722 |
| 74 | neurotransmitter secretion (GO:0007269) | 2.71597132 |
| 75 | intraciliary transport (GO:0042073) | 2.71465381 |
| 76 | sequestering of actin monomers (GO:0042989) | 2.71157529 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.70981771 |
| 78 | response to host immune response (GO:0052572) | 2.69584542 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69584542 |
| 80 | cellular extravasation (GO:0045123) | 2.67870724 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.66622110 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 2.65107410 |
| 83 | synaptic vesicle transport (GO:0048489) | 2.64668156 |
| 84 | establishment of synaptic vesicle localization (GO:0097480) | 2.64668156 |
| 85 | regulation of dopamine secretion (GO:0014059) | 2.64522320 |
| 86 | auditory behavior (GO:0031223) | 2.63867845 |
| 87 | protein localization to cilium (GO:0061512) | 2.62671122 |
| 88 | glutamate receptor signaling pathway (GO:0007215) | 2.60984338 |
| 89 | olfactory bulb development (GO:0021772) | 2.60200512 |
| 90 | myeloid cell activation involved in immune response (GO:0002275) | 2.57933704 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.57134663 |
| 92 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.57092212 |
| 93 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.54292758 |
| 94 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.54157955 |
| 95 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.52787100 |
| 96 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.52010049 |
| 97 | behavioral response to nicotine (GO:0035095) | 2.51912134 |
| 98 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.51049508 |
| 99 | detection of biotic stimulus (GO:0009595) | 2.50388975 |
| 100 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.49491780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.72398243 |
| 2 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.61120126 |
| 3 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.94994924 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90606176 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.45312150 |
| 6 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.44440958 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.31140378 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26583281 |
| 9 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.22014522 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18228323 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08236834 |
| 12 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.04212183 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01869529 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97612515 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97482137 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85848321 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85729065 |
| 18 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.80668690 |
| 19 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80668690 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79577746 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79164847 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77744456 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72535873 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69601602 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68993689 |
| 26 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.67404493 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61339285 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.60458378 |
| 29 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59525877 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52711757 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51634467 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50233529 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48799833 |
| 34 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44732186 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44296159 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44203201 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41955131 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40145258 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40145258 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37037308 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33383143 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30895989 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30071579 |
| 44 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.27899649 |
| 45 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26213365 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25402438 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24982627 |
| 48 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.24352543 |
| 49 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.24166309 |
| 50 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20575154 |
| 51 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.19550046 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19105685 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.18399625 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16584380 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15369895 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14201641 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13070382 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12442617 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09999588 |
| 60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09306316 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08483888 |
| 62 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06782666 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06377602 |
| 64 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06041277 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05499032 |
| 66 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05258955 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04511222 |
| 68 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03647049 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03053585 |
| 70 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00782515 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00312871 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99588842 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99412829 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98800144 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98712698 |
| 76 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96879389 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96702611 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96509143 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96390264 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96063415 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95878240 |
| 82 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95192440 |
| 83 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.94794302 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93198460 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92303385 |
| 86 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91818929 |
| 87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89210406 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87583790 |
| 89 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87485747 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 0.85560527 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85357091 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84840567 |
| 93 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.84747612 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 0.83053389 |
| 95 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82717886 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82708699 |
| 97 | JUN_21703547_ChIP-Seq_K562_Human | 0.82371101 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81821383 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81539224 |
| 100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.81422267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.85723804 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.84475338 |
| 3 | MP0003122_maternal_imprinting | 3.28044961 |
| 4 | MP0003787_abnormal_imprinting | 3.23829591 |
| 5 | MP0002653_abnormal_ependyma_morphology | 2.95322071 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.89039239 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.64734320 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.57836254 |
| 9 | MP0002822_catalepsy | 2.42476259 |
| 10 | MP0003121_genomic_imprinting | 2.33723952 |
| 11 | MP0009745_abnormal_behavioral_response | 2.26959040 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.26096258 |
| 13 | MP0002064_seizures | 2.25189435 |
| 14 | MP0004270_analgesia | 2.24159947 |
| 15 | MP0002272_abnormal_nervous_system | 2.22356449 |
| 16 | MP0001486_abnormal_startle_reflex | 2.18412537 |
| 17 | MP0003724_increased_susceptibility_to | 2.16841783 |
| 18 | MP0000778_abnormal_nervous_system | 2.10957488 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.07719579 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.02875212 |
| 21 | MP0003123_paternal_imprinting | 1.94671939 |
| 22 | MP0002102_abnormal_ear_morphology | 1.91289502 |
| 23 | MP0005248_abnormal_Harderian_gland | 1.86874913 |
| 24 | MP0003878_abnormal_ear_physiology | 1.86105990 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 1.86105990 |
| 26 | MP0009046_muscle_twitch | 1.85019527 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 1.82012207 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.80505652 |
| 29 | MP0002736_abnormal_nociception_after | 1.71254089 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.68130869 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.63728669 |
| 32 | MP0001188_hyperpigmentation | 1.63489111 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.55648145 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.55306164 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.54721316 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.50596085 |
| 37 | MP0004742_abnormal_vestibular_system | 1.49941707 |
| 38 | MP0003303_peritoneal_inflammation | 1.49671427 |
| 39 | MP0001984_abnormal_olfaction | 1.49326046 |
| 40 | MP0001970_abnormal_pain_threshold | 1.48161922 |
| 41 | MP0005499_abnormal_olfactory_system | 1.43200928 |
| 42 | MP0005394_taste/olfaction_phenotype | 1.43200928 |
| 43 | MP0004142_abnormal_muscle_tone | 1.42723572 |
| 44 | MP0001485_abnormal_pinna_reflex | 1.42398840 |
| 45 | MP0001529_abnormal_vocalization | 1.40390966 |
| 46 | MP0001293_anophthalmia | 1.35832189 |
| 47 | MP0002735_abnormal_chemical_nociception | 1.33896422 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.33883215 |
| 49 | MP0008260_abnormal_autophagy | 1.32487889 |
| 50 | MP0003690_abnormal_glial_cell | 1.31999695 |
| 51 | MP0000955_abnormal_spinal_cord | 1.30501403 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.26429249 |
| 53 | MP0008569_lethality_at_weaning | 1.24762589 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.21692110 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.21657584 |
| 56 | MP0003329_amyloid_beta_deposits | 1.19482957 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 1.14313266 |
| 58 | MP0002152_abnormal_brain_morphology | 1.11709640 |
| 59 | MP0003633_abnormal_nervous_system | 1.11510146 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.08759701 |
| 61 | MP0009278_abnormal_bone_marrow | 1.08346936 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.03761803 |
| 63 | MP0001963_abnormal_hearing_physiology | 1.01039244 |
| 64 | MP0003436_decreased_susceptibility_to | 1.00208341 |
| 65 | MP0003172_abnormal_lysosome_physiology | 0.99725995 |
| 66 | MP0002419_abnormal_innate_immunity | 0.99660012 |
| 67 | MP0009764_decreased_sensitivity_to | 0.97000331 |
| 68 | MP0002066_abnormal_motor_capabilities/c | 0.94822915 |
| 69 | MP0002752_abnormal_somatic_nervous | 0.93795878 |
| 70 | MP0001324_abnormal_eye_pigmentation | 0.91941179 |
| 71 | MP0003631_nervous_system_phenotype | 0.91856080 |
| 72 | MP0009379_abnormal_foot_pigmentation | 0.90936661 |
| 73 | MP0003938_abnormal_ear_development | 0.90573614 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.89872675 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 0.89655956 |
| 76 | MP0003136_yellow_coat_color | 0.89098878 |
| 77 | MP0005386_behavior/neurological_phenoty | 0.88751146 |
| 78 | MP0004924_abnormal_behavior | 0.88751146 |
| 79 | MP0001905_abnormal_dopamine_level | 0.85975404 |
| 80 | MP0000604_amyloidosis | 0.85214126 |
| 81 | MP0000026_abnormal_inner_ear | 0.85077314 |
| 82 | MP0002928_abnormal_bile_duct | 0.85050853 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.85024015 |
| 84 | MP0005171_absent_coat_pigmentation | 0.84920854 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.84208590 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 0.82783746 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.82079466 |
| 88 | MP0003879_abnormal_hair_cell | 0.82011471 |
| 89 | MP0004885_abnormal_endolymph | 0.82001855 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.79974009 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.79812460 |
| 92 | MP0002229_neurodegeneration | 0.79704107 |
| 93 | MP0000920_abnormal_myelination | 0.79404394 |
| 94 | MP0002184_abnormal_innervation | 0.78123146 |
| 95 | MP0005253_abnormal_eye_physiology | 0.76079361 |
| 96 | MP0004133_heterotaxia | 0.74248707 |
| 97 | MP0003861_abnormal_nervous_system | 0.73466335 |
| 98 | MP0009785_altered_susceptibility_to | 0.71718647 |
| 99 | MP0005195_abnormal_posterior_eye | 0.70340931 |
| 100 | MP0006082_CNS_inflammation | 0.69072927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.84651329 |
| 2 | Focal motor seizures (HP:0011153) | 4.24079029 |
| 3 | Febrile seizures (HP:0002373) | 3.81480633 |
| 4 | Focal seizures (HP:0007359) | 3.57518071 |
| 5 | Polyphagia (HP:0002591) | 3.46768764 |
| 6 | Limb dystonia (HP:0002451) | 3.20135617 |
| 7 | Atonic seizures (HP:0010819) | 3.19467366 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.06691169 |
| 9 | Septo-optic dysplasia (HP:0100842) | 2.99898295 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 2.98972144 |
| 11 | Optic neuritis (HP:0100653) | 2.96712382 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 2.96712382 |
| 13 | Agnosia (HP:0010524) | 2.92688750 |
| 14 | Gait imbalance (HP:0002141) | 2.88509605 |
| 15 | Orchitis (HP:0100796) | 2.83309376 |
| 16 | Mutism (HP:0002300) | 2.78875579 |
| 17 | Abnormal eating behavior (HP:0100738) | 2.77029960 |
| 18 | Myositis (HP:0100614) | 2.76659729 |
| 19 | Action tremor (HP:0002345) | 2.75933909 |
| 20 | Epileptic encephalopathy (HP:0200134) | 2.75297256 |
| 21 | Stomatitis (HP:0010280) | 2.75002419 |
| 22 | Agitation (HP:0000713) | 2.64402917 |
| 23 | Recurrent abscess formation (HP:0002722) | 2.59515097 |
| 24 | Hypochromic microcytic anemia (HP:0004840) | 2.55368051 |
| 25 | Dialeptic seizures (HP:0011146) | 2.53185210 |
| 26 | Inappropriate behavior (HP:0000719) | 2.53071417 |
| 27 | Disinhibition (HP:0000734) | 2.52728027 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 2.51625853 |
| 29 | Amyotrophic lateral sclerosis (HP:0007354) | 2.51074814 |
| 30 | Postural instability (HP:0002172) | 2.50937111 |
| 31 | Visual hallucinations (HP:0002367) | 2.47771770 |
| 32 | Congenital primary aphakia (HP:0007707) | 2.46235953 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.45810612 |
| 34 | Diplopia (HP:0000651) | 2.42343761 |
| 35 | Abnormality of binocular vision (HP:0011514) | 2.42343761 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40886116 |
| 37 | Excessive salivation (HP:0003781) | 2.40633642 |
| 38 | Peripheral hypomyelination (HP:0007182) | 2.40583200 |
| 39 | Growth hormone deficiency (HP:0000824) | 2.36906865 |
| 40 | Drooling (HP:0002307) | 2.36361378 |
| 41 | Nephrogenic diabetes insipidus (HP:0009806) | 2.33849854 |
| 42 | Spastic gait (HP:0002064) | 2.33619823 |
| 43 | Medial flaring of the eyebrow (HP:0010747) | 2.30852362 |
| 44 | Oligodactyly (hands) (HP:0001180) | 2.30176336 |
| 45 | Colon cancer (HP:0003003) | 2.28950093 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.27669737 |
| 47 | True hermaphroditism (HP:0010459) | 2.22060490 |
| 48 | Iris hypopigmentation (HP:0007730) | 2.21670765 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21653901 |
| 50 | Absence seizures (HP:0002121) | 2.20794447 |
| 51 | Anophthalmia (HP:0000528) | 2.17912737 |
| 52 | Abnormality of the labia minora (HP:0012880) | 2.17463266 |
| 53 | Papilledema (HP:0001085) | 2.17332764 |
| 54 | Supranuclear gaze palsy (HP:0000605) | 2.16957868 |
| 55 | Nephronophthisis (HP:0000090) | 2.15889350 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10995060 |
| 57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10508253 |
| 58 | Pancreatic fibrosis (HP:0100732) | 2.10181133 |
| 59 | Specific learning disability (HP:0001328) | 2.09861182 |
| 60 | Oligodactyly (HP:0012165) | 2.06792885 |
| 61 | Broad-based gait (HP:0002136) | 2.03080907 |
| 62 | Amyloidosis (HP:0011034) | 2.02765368 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.01928362 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01927032 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01927032 |
| 66 | Sleep apnea (HP:0010535) | 1.98518691 |
| 67 | Optic nerve hypoplasia (HP:0000609) | 1.98477295 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 1.97376152 |
| 69 | Dyskinesia (HP:0100660) | 1.96001929 |
| 70 | Abnormality of macrophages (HP:0004311) | 1.95625395 |
| 71 | Breast aplasia (HP:0100783) | 1.95213546 |
| 72 | Amblyopia (HP:0000646) | 1.95014689 |
| 73 | Vaginal atresia (HP:0000148) | 1.93910392 |
| 74 | Erectile abnormalities (HP:0100639) | 1.92837020 |
| 75 | Eczematoid dermatitis (HP:0000976) | 1.91096369 |
| 76 | Genital tract atresia (HP:0001827) | 1.90420547 |
| 77 | Urinary urgency (HP:0000012) | 1.89359900 |
| 78 | Obstructive lung disease (HP:0006536) | 1.87823987 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87823987 |
| 80 | Hip dysplasia (HP:0001385) | 1.86748644 |
| 81 | Ocular albinism (HP:0001107) | 1.86626891 |
| 82 | Absent septum pellucidum (HP:0001331) | 1.86242634 |
| 83 | Molar tooth sign on MRI (HP:0002419) | 1.85410906 |
| 84 | Abnormality of midbrain morphology (HP:0002418) | 1.85410906 |
| 85 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.84660684 |
| 86 | Keratoconjunctivitis (HP:0001096) | 1.83760571 |
| 87 | Poor coordination (HP:0002370) | 1.80201996 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80162674 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78993946 |
| 90 | Abnormal social behavior (HP:0012433) | 1.77231523 |
| 91 | Impaired social interactions (HP:0000735) | 1.77231523 |
| 92 | Status epilepticus (HP:0002133) | 1.76837958 |
| 93 | Hemiplegia (HP:0002301) | 1.76736145 |
| 94 | Rib fusion (HP:0000902) | 1.76044395 |
| 95 | Annular pancreas (HP:0001734) | 1.75210666 |
| 96 | Pancreatic cysts (HP:0001737) | 1.74371541 |
| 97 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74180430 |
| 98 | Broad foot (HP:0001769) | 1.74039597 |
| 99 | Cortical dysplasia (HP:0002539) | 1.73499341 |
| 100 | Mediastinal lymphadenopathy (HP:0100721) | 1.71833817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.40020931 |
| 2 | CDK19 | 3.34254505 |
| 3 | RIPK4 | 2.80009815 |
| 4 | CASK | 2.40192380 |
| 5 | MARK1 | 2.23472234 |
| 6 | MINK1 | 2.18345574 |
| 7 | UHMK1 | 2.11536668 |
| 8 | DYRK3 | 2.08916085 |
| 9 | MAP3K4 | 2.00618579 |
| 10 | MAP2K7 | 1.98442019 |
| 11 | FGR | 1.98111569 |
| 12 | DAPK2 | 1.95349061 |
| 13 | NTRK2 | 1.87735368 |
| 14 | MAP2K4 | 1.83249670 |
| 15 | TNIK | 1.80286944 |
| 16 | PAK6 | 1.77580551 |
| 17 | NTRK3 | 1.74657627 |
| 18 | MAP3K11 | 1.67262489 |
| 19 | DYRK2 | 1.65403648 |
| 20 | MAPK13 | 1.63653866 |
| 21 | WNK3 | 1.46159111 |
| 22 | BLK | 1.44971479 |
| 23 | PLK2 | 1.43899097 |
| 24 | CAMKK2 | 1.43392600 |
| 25 | CAMKK1 | 1.41895060 |
| 26 | DYRK1A | 1.35988530 |
| 27 | DYRK1B | 1.33997171 |
| 28 | MARK2 | 1.29650984 |
| 29 | TYRO3 | 1.29307650 |
| 30 | STK11 | 1.28085518 |
| 31 | FES | 1.26809415 |
| 32 | PRKCG | 1.18727479 |
| 33 | CAMK1 | 1.15977909 |
| 34 | PINK1 | 1.15726675 |
| 35 | TNK2 | 1.14338561 |
| 36 | SGK223 | 1.11922609 |
| 37 | SGK494 | 1.11922609 |
| 38 | CSNK1G2 | 1.11772286 |
| 39 | IRAK4 | 1.10970784 |
| 40 | CDK5 | 1.10741695 |
| 41 | CSK | 1.09921022 |
| 42 | GRK5 | 1.05420755 |
| 43 | SGK2 | 1.04454873 |
| 44 | SIK2 | 1.04432566 |
| 45 | CAMK4 | 1.00201585 |
| 46 | IRAK2 | 0.98896712 |
| 47 | TAOK1 | 0.98138091 |
| 48 | KSR1 | 0.95248855 |
| 49 | MAP3K6 | 0.91990567 |
| 50 | MKNK2 | 0.90518896 |
| 51 | PAK3 | 0.85357168 |
| 52 | CDK14 | 0.83970967 |
| 53 | BCR | 0.83170163 |
| 54 | MAP3K9 | 0.82807075 |
| 55 | MKNK1 | 0.82633264 |
| 56 | TRIM28 | 0.81304679 |
| 57 | OXSR1 | 0.81228064 |
| 58 | MATK | 0.78854144 |
| 59 | BRAF | 0.78029942 |
| 60 | SGK3 | 0.76593111 |
| 61 | CDK15 | 0.75723612 |
| 62 | CDK18 | 0.75331169 |
| 63 | CDC7 | 0.74793958 |
| 64 | CSNK1G3 | 0.74077995 |
| 65 | CDK11A | 0.72802869 |
| 66 | JAK2 | 0.71604307 |
| 67 | PRKCH | 0.70921642 |
| 68 | RPS6KA4 | 0.70262432 |
| 69 | SYK | 0.69666114 |
| 70 | TYK2 | 0.68921960 |
| 71 | ERBB2 | 0.65187316 |
| 72 | PNCK | 0.64349211 |
| 73 | PTK2B | 0.63214784 |
| 74 | PRKCZ | 0.61299001 |
| 75 | CAMK2A | 0.59386926 |
| 76 | YES1 | 0.59154937 |
| 77 | MAP2K3 | 0.59036714 |
| 78 | ADRBK2 | 0.58924147 |
| 79 | SGK1 | 0.58749190 |
| 80 | PRKD3 | 0.58109460 |
| 81 | CSNK1A1L | 0.57948598 |
| 82 | KSR2 | 0.55635312 |
| 83 | TXK | 0.55491772 |
| 84 | GRK7 | 0.54598234 |
| 85 | GRK6 | 0.52470360 |
| 86 | LYN | 0.51446371 |
| 87 | CSNK1G1 | 0.51238462 |
| 88 | FYN | 0.51132582 |
| 89 | CAMK1G | 0.50800977 |
| 90 | PLK3 | 0.49712783 |
| 91 | HCK | 0.47145926 |
| 92 | ALK | 0.44585897 |
| 93 | MAP3K5 | 0.43980876 |
| 94 | BCKDK | 0.43511327 |
| 95 | BTK | 0.42219866 |
| 96 | IKBKE | 0.40243914 |
| 97 | MAP4K2 | 0.40003203 |
| 98 | MARK3 | 0.38898094 |
| 99 | SRPK1 | 0.35115362 |
| 100 | CAMK1D | 0.35076237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.35432061 |
| 2 | Morphine addiction_Homo sapiens_hsa05032 | 2.75429372 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72979145 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67068963 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60281973 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17620254 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.04863410 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03859862 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93596351 |
| 10 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.83443304 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.80419134 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77596254 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.71401899 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.66884623 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66760568 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66478919 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.58889945 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.51977533 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.50560025 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.47786663 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45151652 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.43060683 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.37461408 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36051631 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35567030 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.34022317 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33151668 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.25466137 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.25338512 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24205763 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23101799 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.22528007 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22282651 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17302889 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.15455606 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15099226 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15044685 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14653084 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07762419 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05462584 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.05453110 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03647191 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00761262 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.99398722 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98659352 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.98449396 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97610568 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.96604265 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95048817 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.94673406 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93713036 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.93544749 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.91557253 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89708768 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87042089 |
| 56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84411387 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83619099 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80495280 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80336762 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79987236 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79844949 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79594719 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.78890604 |
| 64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76894468 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76091051 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76083214 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75611424 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72248298 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69853592 |
| 70 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69418966 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.68836749 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 0.67659784 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65537263 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65098904 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65013754 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64873436 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64011831 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63205364 |
| 79 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.62908668 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61181107 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.59797089 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59480031 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58178297 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55658067 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55233589 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55199743 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54563096 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53948704 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51972316 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51378062 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50881954 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47790533 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47058568 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46081612 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43813700 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43807033 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42859348 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.42580578 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41005068 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39508110 |

